PREDICTIVE FACTORS OF BIOLOGIC DISEASEMODIFYING ANTI-RHEUMATIC DRUGS (BDMARD) USE IN JUVENILE IDIOPATHIC ARTHRITIS PATIENTS

被引：0
|
作者：
Martins, A. [1 ,2 ]
Ganhao, S. [3 ]
Pinheiro, F. Oliveira [1 ,2 ]
Morais, C. [4 ]
Leuzinger-Dias, M. [5 ]
Rodrigues, M. [3 ]
Figueira, L. [5 ]
Brito, I. [2 ,3 ]
机构：
[1] Sao Joao Univ Hosp Ctr, Rheumatol, Porto, Portugal
[2] Fac Med Univ Porto FMUP, Med, Porto, Portugal
[3] Sao Joao Univ Hosp Ctr, Pediat & Young Adult Rheumatol Unit, Porto, Portugal
[4] Sao Joao Univ Hosp Ctr, Pediat, Porto, Portugal
[5] Sao Joao Univ Hosp Ctr, Ophthalmol, Porto, Portugal
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
bDMARD;
D O I：
10.1136/annrheumdis-2023-eular.1102
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1414
引用
收藏
页码：1935 / 1936
页数：2
相关论文
共 50 条
  • [31] Predictors at Diagnosis for Start of Biologic Disease Modifying Anti-Rheumatic Drugs in Patients with Early Rheumatoid Arthritis
    Hameed, Mohaned
    Exarchou, Sofia
    Eberhard, Anna
    Sharma, Ankita
    Bergstrom, Ulf
    Einarsson, Jon
    Turesson, Carl
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2831 - 2833
  • [32] Factors predictive of treatment success of novel disease-modifying anti-rheumatic drugs (DMARDS) in patients with inflammatory arthritis
    Overbeek, Jetty A.
    Herings, Ron
    Moens, Hein J. Bernelot
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 229 - 229
  • [33] THE MODERATING EFFECTS OF DEPRESSION ON BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS
    Rathbun, A. M.
    Harrold, L. R.
    Reed, G. W.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 631 - 631
  • [34] Effectiveness of sequential biologic and targeted disease modifying anti-rheumatic drugs for rheumatoid arthritis
    Zhao, Sizheng Steven
    Kearlsey-Fleet, Lianne
    Bosworth, Ailsa
    Watson, Kath
    Hyrich, Kimme L.
    RHEUMATOLOGY, 2022, 61 (12) : 4678 - 4686
  • [35] Utilization of Biologic and Non-Biologic Disease Modifying Anti-Rheumatic Drugs in the Treatment of Juvenile Idiopathic Arthritis: A Cross-Sectional Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry.
    Beukelman, Timothy
    Ringold, Sarah
    Davis, Trevor
    DeWitt, Esi M. Morgan
    Pelajo, Christina F.
    Weiss, Pamela
    Kimura, Yukiko
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S104 - S104
  • [36] Use of disease-modifying anti-rheumatic drugs and cardiovascular events in patients with rheumatoid arthritis
    Kaminski, Matthew
    Shishehbor, Mehdi H.
    Gutierrez, Antonio
    Amini, Mohammad R.
    Coats, Walter
    Moghbelli, Meisam
    Askari, Arman T.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A370 - A370
  • [37] ANTI-RHEUMATIC NONSTEROID DRUGS IN THERAPY OF PATIENTS WITH RHEUMATOID-ARTHRITIS
    DORMIDONTOV, EN
    KORSHUNOV, NI
    BARANOVA, EY
    TERAPEVTICHESKII ARKHIV, 1978, 50 (09) : 10 - 13
  • [38] Health Care Resource Utilization and Costs in Patients with Juvenile Idiopathic Arthritis Treated with Abatacept and Other Targeted Disease Modifying Anti-rheumatic Drugs
    Zhuo, Joe
    Bao, Ying
    Xia, Qian
    Rao, Aarti
    Sharma, Niyati
    Han, Xue
    Wong, Robert
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [39] The role of registries in the treatment of rheumatoid arthritis with biologic disease-modifying anti-rheumatic drugs
    Pombo-Suarez, Manuel
    Gomez-Reino, Juan
    PHARMACOLOGICAL RESEARCH, 2019, 148
  • [40] Predictive factors for withdrawal of disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis (RA): Is age relevant?
    Mok, CC
    Ng, WL
    Yim, CW
    Wong, RWS
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S172 - S172
12345